Search

Search Results

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

  A.S. Kolbin, Yuliya Mikhailovna Gomon, Yu.E. Balykina, M.A. Proskurin

  85-96

  01.01.2022

• Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

  Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva

  321-332

  01.07.2021

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan

  150-159

  01.04.2018

• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy

  Vasilii Anatol’evich Shuvaev, S.V. Voloshin, A.K. Hadzhidis, A.V. Chechetkin

  435-442

  01.10.2017

• Supportive (Maintenance) Therapy in Hematopoietic Stem Cell Transplantation: Main Principles and New Perspectives

  Vasilii Petrovich Pop, O.A. Rukavitsyn

  501-513

  01.10.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome

  Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev

  366-371

  01.07.2017

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

  Tat’yana Ivanovna Ionova, N.B. Bulieva, O.Yu. Vinogradova, T.A. Gritsenko, L.K. Kozlova, G.B. Kuchma, E.G. Lomaia, E.R. Machyulaitene, T.P. Nikitina, N.V. Novitskaya, A.Yu. Rodionova, E.I. Usacheva, T.V. Shneider

  206-217

  01.04.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, O.A. Slesarchuk, A.G. Smirnova, O.S. Uspenskaya, Ya.V. Gudozhnikova, A.A. Osipova, V.S. Sergeev, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev

  45-51

  01.01.2017

• Anemias in Oncology: Potential of Maintenance Therapy

  Anton Vladimirovich Snegovoi, V.B. Larionova, L.V. Manzyuk, I.B. Kononenko

  326-335

  01.07.2016

• Prevention of Nausea and Vomiting in Oncology

  Anton Vladimirovich Snegovoi, V.B. Larionova, I.B. Kononenko, L.V. Manzyuk, A.I. Saltanov, V.Yu. Sel’chuk

  75-83

  01.01.2016

• Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

  N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa

  13-21

  01.01.2016

• Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

  Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Kuzyaeva, I.M. Zapreeva, E.V. Litvinskaya, L.V. Stel’mashenko, S.A. Tiranova, I.S. Martynkevich, N.A. Potikhonova, K.M. Abdulkadyrov

  48-53

  01.01.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Polycythemia Vera: Literature Review and Own Data

  Irina Nikolaevna Subortseva, T.I. Kolosheinova, E.I. Pustovaya, E.K. Egorova, A.M. Kovrigina, Yu.V. Pliskunova, T.V. Makarik, A.O. Abdullaev, A.L. Melikyan

  397-412

  01.10.2015

• Hematological Improvement is a Favorable Response to Azacitidine in Patients with Acute Myeloid Leukemias and Myelodysplastic Syndromes

  Ivan Ivanovich Kostroma, S.V. Gritsaev, E.V. Karyagina, A.S. Nizamutdinova, I.S. Martynkevich, K.M. Abdulkadyrov

  413-419

  01.10.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• Anorexia-Cachexia Syndrome in Cancer Patients

  Anton Vladimirovich Snegovoi, I.B. Kononenko, V.B. Larionova, A.I. Saltanov, V.Yu. Sel’chuk

  185-190

  01.04.2015

• First Line Treatment Choice for Chronic Myelogenous Leukemia: Modeling of Clinical and Economic Factors

  Vasilii Anatol’evich Shuvaev, K.M. Abdulkadyrov, I.S. Martynkevich, M.S. Fominykh

  78–83

  01.01.2015

• Clinical significance of the whole-exome studies in myeloid neoplasms using next-generation sequencing

  S.A. Smirnikhina, A.V. Lavrov, E.P. Adilgereeva, A.G. Turkina, S.I. Kutsev

  12-19

  01.01.2013